| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04215731 | Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced… | Rectal Cancer | Recruiting |
| NCT05427669 | Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD) | Colorectal Cancer | Not Yet Recruiting |
| NCT04230187 | Bevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable… | Colorectal Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT05450029 | Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally… | Rectal Cancer | Recruiting |
| NCT05360277 | Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer | Metastatic Colorectal Cancer，NED | Recruiting |
| Not specified | |||
| NCT06883084 | Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal… | Rectal Cancer | Enrolling by Invitation |
| NCT06779474 | Laparoscopic Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy… | Colorectal Liver Metastases | Not Yet Recruiting |